CoChat

Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment

Van Gaal, Luc, Scheen, André · 2015 · Diabetes Care

The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.

Abstract

Diabetes is a growing global health concern, as is obesity. Diabetes and obesity are intrinsically linked: obesity increases the risk of diabetes and also contributes to disease progression and cardiovascular disease. Although the benefits of weight loss in the prevention of diabetes and as a critical component of managing the condition are well established, weight reduction remains challenging for individuals with type 2 diabetes due to a host of metabolic and psychological factors. For many patients, lifestyle intervention is not enough to achieve weight loss, and alternative options, such as pharmacotherapy, need to be considered. However, many traditional glucose-lowering medications may lead to weight gain. This article focuses on the potential of currently available pharmacological strategies and on emerging approaches in development to support the glycemic and weight-loss goals of individuals with type 2 diabetes. Two pharmacotherapy types are considered: those developed primarily for blood glucose control that have a favorable effect on body weight and those developed primarily to induce weight loss that have a favorable effect on blood glucose control. Finally, the potential of combination therapies for the management of obese patients with type 2 diabetes is discussed.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc14-1630

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Research works printed but not linked: 1

  1. Ferrannini, 2014, Energy balance following sodium-glucose co-transporter-2 (SGLT2) inhibition, Diabetologia, 57, S8

Cited by

See all 221

Metadata

Authors
Van Gaal, L., & Scheen, A.
Affiliations
  • Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerp, Belgium
  • University of Liège (BE)
Venue
Diabetes Care
Published
2015-05-12
Volume
38
Issue
6
Pages
1161-1172
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1893948433
Cited by
221
References
112
Citations by year
2026: 5 · 2025: 12 · 2024: 22 · 2023: 19 · 2022: 17 · 2021: 18 · 2020: 24 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 24 · 2015: 8
FWCI
4.06
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • ORBi (University of Liège) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, obesity, weight management, weight loss, pharmacotherapy, glucose-lowering medications, anti-obesity drugs, glycemic control, combination therapy, lifestyle intervention
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Drug Therapy, Combination, Forecasting, Humans, Hypoglycemic Agents, Obesity, Weight Gain, Weight Loss, Anti-Obesity Agents, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.